Clovis Oncology, Inc. (CLVS) Social Stream
Clovis Oncology Inc (CLVS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CLVS.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CLVS's average price target has moved down $0.1 over the prior 129 days.
CLVS reports an average of 18.08% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CLVS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CLVS's average broker recommendation rating improved by 0.58 over the prior 31 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Clovis Oncology Inc's average analyst price target is greater than 10.06% of all US stocks.
- Clovis Oncology Inc's upside potential (average analyst target price relative to current price) is higher than 181.29% of stocks in the mid market cap category.
- CLVS has a higher number of analysts covering the stock than 24.9% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, Clovis Oncology Inc's variance in analysts' estimates is lower than -9.65% of them.
Make investment decisions regarding CLVS using the data that counts. Try POWR Ratings for free.